TrialBiological psychiatry2023

Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo-Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist d-serine.

Pejman Sehatpour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.